Meta-analysis results for all treatments

Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method

Treament Trials      
clinical deteriorationclinical improvementdeathsviral clearance
ivermectin1----
zinc1- 1.08 [0.54; 2.15], 1 RCT, I2=0%
inconclusive result
0.99 [0.28; 3.53], 1 RCT, I2=0%
inconclusive result
-
Amantadine0----
ASC09/ritonavir0----
azithromycin0----
azvudine0----
baloxavir marboxil0----
bromhexine0----
carrimycin0----
chloroquine and derivatives0----
danoprevir / ritonavir0----
darunavir cobicistat0----
doxycycline0----
Emtricitabine/tenofovir plus colchicine plus rosuvastatin0----
Ensitrelvir (XOCOVA)0----
favipiravir 0----
favipiravir plus interferon0----
fluvoxamine0----
hydroxychloroquine plus macrolides0----
Interferon plus lopinavir/ritonavir0----
leronlimab0----
lopinavir / ritonavir plus ribavirin0----
lopinavir/ritonavir0----
lopinavir/ritonavir plus chloroquine0----
Lopinavir/ritonavir plus hydroxychloroquine0----
lopinavir/ritonavir plus interferon ß-1a0----
lopinavir/ritonavir, ribavirin and interferon beta-1b0----
molnupiravir0----
niclosamide0----
nirmatrelvir / ritonavir (Paxlovid)0----
nitazoxanide0----
opaganib0----
oseltamivir0----
oseltamivir plus chloroquin0----
remdesivir0----
ribavirin0----
ritonavir0----
sofosbuvir0----
sofosbuvir and daclatasvir0----
sofosbuvir and ledipasvir0----
tenofovir/emtricitabine0----
tenofovir/emtricitabine plus hydroxychloroquine0----
tranexamic acid0----
tranilast0----
triazavirin0----
umifenovir (arbidol)0----